mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.2 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |